Clinical trial

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

NCT03638778

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-08-17

PhasePHASE1

Study timeline

Study start (actual)2018-08-17Date precision: day

Registry last updated2019-11-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Semaglutide 3 mgDRUG · verified · RxNorm: semaglutide 3 MG

Semaglutide 7 mgDRUG · verified · RxNorm: semaglutide 7 MG

Semaglutide B 3 mgDRUG

Semaglutide B 7 mgDRUG

Semaglutide C 3 mgDRUG

Semaglutide C 7 mgDRUG

Semaglutide D 3 mgDRUG

Semaglutide D 7 mgDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03638778 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.